Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 2 Sarcoma, Ewing 1 Recurrence 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Osteosarcoma 1 Gallbladder Neoplasms 1 Feeding Behavior 1 Cholangiocarcinoma 1 Bone Neoplasms 1

Interventions

Cyclophosphamide 16 Temozolomide 13 Vincristine 10 Irinotecan 8 Melphalan 7 Doxorubicin 7 Topotecan 6 Granulocyte Colony-Stimulating Factor 6 Busulfan 6 fludarabine 5 cabozantinib 5 Etoposide 5 Drug Therapy 5 liposomal doxorubicin 4 Sirolimus 4 Ifosfamide 4 Filgrastim 4 regorafenib 3 pegfilgrastim 3 irinotecan sucrosofate 3 fludarabine phosphate 3 Zoledronic Acid 3 Radiotherapy 3 Nivolumab 3 Magnetic Resonance Spectroscopy 3 Gemcitabine 3 Cisplatin 3 Bone Marrow Transplantation 3 Albumin-Bound Paclitaxel 3 pegylated granulocyte colony-stimulating factor 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Sarcoma, Ewing × Microbiota × Clear all

NCT04735289 2023-08-04

Metabol-Sarc

Istituto Ortopedico Rizzoli

Bone Neoplasms, Feeding Behavior, Sarcoma, Ewing, Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡